Integrating pharmacophore mapping, virtual screening, density functional theory, molecular simulation towards the discovery of novel apolipoprotein (apoE ε4) inhibitors
暂无分享,去创建一个
Surabhi Johari | Ashwani Sharma | Subrata Sinha | Aparoop Das | S. Johari | Ashwani Sharma | Subrata Sinha | Aparoop Das
[1] D. Sriram,et al. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations , 2018, Journal of biomolecular structure & dynamics.
[2] Sugunadevi Sakkiah,et al. Pharmacophore-based virtual screening and density functional theory approach to identifying novel butyrylcholinesterase inhibitors , 2012, Acta Pharmacologica Sinica.
[3] David Calkins,et al. Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution , 2010, J. Comput. Aided Mol. Des..
[4] M. Coumar,et al. BDMC-A, an analog of curcumin, inhibits markers of invasion, angiogenesis, and metastasis in breast cancer cells via NF-κB pathway--A comparative study with curcumin. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] S. Singh,et al. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches , 2019, Journal of biomolecular structure & dynamics.
[6] Rebecca F. Halperin,et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.
[7] Kwang Kim,et al. Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors , 2011, BMC Bioinformatics.
[8] V. Pande,et al. Activation pathway of Src kinase reveals intermediate states as novel targets for drug design , 2014, Nature Communications.
[9] M. Sengupta,et al. Altered Levels of Amyloid Precursor Protein Intracellular Domain-interacting Proteins in Alzheimer Disease , 2014, Alzheimer disease and associated disorders.
[10] Asim Kumar Debnath,et al. Pharmacophore mapping of a series of 2,4-diamino-5-deazapteridine inhibitors of Mycobacterium avium complex dihydrofolate reductase. , 2002, Journal of medicinal chemistry.
[11] M. Dimachkie,et al. Donepezil in the treatment of Alzheimer disease. , 2000 .
[12] Charles L. Brooks,et al. Detailed analysis of grid‐based molecular docking: A case study of CDOCKER—A CHARMm‐based MD docking algorithm , 2003, J. Comput. Chem..
[13] Weiliang Zhu,et al. Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design. , 2010, Physical chemistry chemical physics : PCCP.
[14] Zaheer-ul-Haq,et al. Juliflorine: a potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer's disease therapy. , 2005, Biochemical and biophysical research communications.
[15] J. Haines,et al. Genome-Wide Association Study of Late-Onset Alzheimer Disease Identifies Disease-Associated Variants in MS4A4/MS4A6E, CD2AP, CD33, and EPHA1 , 2011, Alzheimer's & Dementia.
[16] R. Nussbaum. Genome-wide association studies, Alzheimer disease, and understudied populations. , 2013, JAMA.
[17] E. Tadaka,et al. Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting , 2007 .
[18] Aftab Ahmad,et al. Synthesis, molecular docking with COX 1& II enzyme, ADMET screening and in vivo anti-inflammatory activity of oxadiazole, thiadiazole and triazole analogs of felbinac , 2017 .
[19] Arthur J. Olson,et al. Virtual screening with AutoDock Vina and the common pharmacophore engine of a low diversity library of fragments and hits against the three allosteric sites of HIV integrase: participation in the SAMPL4 protein–ligand binding challenge , 2014, Journal of Computer-Aided Molecular Design.
[20] Kai Gu,et al. Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core. , 2017, Current topics in medicinal chemistry.
[21] Diganta Sarma,et al. Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[22] Keun Woo Lee,et al. Pharmacophore modeling, virtual screening, molecular docking studies and density functional theory approaches to identify novel ketohexokinase (KHK) inhibitors , 2015, Biosyst..